About
Dr. Michal Izrael is the Founder & CEO of Leverage Bio Ltd., a startup company focused on developing intravenously injectable disease-modifying treatments (Ageineer©) for Alzheimer's disease and other age-related conditions. Her research is rooted in advancing Regenerative Medicine, with a focus on harnessing the unique properties of young progenitor cells to repair and rejuvenate aging tissues. She also has extensive experience in cell-therapy product development, specifically in developing pluripotent stem cell-based clinical-grade cell therapies for neurodegenerative diseases (e.g., ALS) and Diabetes. Prior to founding Leverage Bio, Dr. Izrael held various leadership roles at Kadimastem Ltd., including VP of Research and Development, where she was instrumental in developing cell therapy products for ALS (AstroRx®) and insulin-secreting islets (IsletRx) for diabetes.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is Dr. Michal Izrael's primary investment focus by sector?
- Dr. Michal Izrael primarily focuses on the Health Tech & Life Sciences sector, with one investment in this area.
- Can you name a notable company in Dr. Michal Izrael's portfolio?
- Dr. Michal Izrael's portfolio includes NewCelX, a company focused on cell therapies for neurodegenerative and metabolic diseases.
- What is the funding stage of NewCelX, a company in Dr. Michal Izrael's portfolio?
- NewCelX, a company in Dr. Michal Izrael's portfolio, is in the Mature funding stage and has raised $45.35M.
- When did Dr. Michal Izrael make her most recent investment?
- Dr. Michal Izrael made an investment in October 2018.
- What is Dr. Michal Izrael's investment range?
- Dr. Michal Izrael's investment range is between $5.15M and $5.15M.
- What type of investor is Dr. Michal Izrael?
- Dr. Michal Izrael is an angel investor based in Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2025 |
|---|